Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Clean Energy Fuels
CLNE
$395M
| $9.38M | ﹤0.01% |
1,150,623
+304,347
| +36% | +$2.42M |
|
2052
Microvast
MVST
$341M
| $9.38M | ﹤0.01% |
+1,140,425
| New | +$11.9M |
|
|
NVEE
2053
DELISTED
NV5 Global
NVEE
| $9.36M | ﹤0.01% |
379,676
-8,240
| -2% | -$203K |
|
2054
Porch Group
PRCH
$1.92B
| $9.35M | ﹤0.01% |
528,539
+135,096
| +34% | +$2.54M |
|
|
RAD
2055
DELISTED
Rite Aid Corporation
RAD
| $9.34M | ﹤0.01% |
657,820
-13,255
| -2% | -$209K |
|
2056
Alector
ALEC
$228M
| $9.27M | ﹤0.01% |
406,112
+31,919
| +9% | +$894K |
|
2057
Nabors Industries
NBR
$1.35B
| $9.25M | ﹤0.01% |
95,889
-504
| -0.5% | -$43.8K |
|
2058
AerCap
AER
$23.5B
| $9.19M | ﹤0.01% |
158,897
-137
| -0.1% | -$7.34K |
|
|
CSII
2059
DELISTED
Cardiovascular Systems, Inc.
CSII
| $9.16M | ﹤0.01% |
279,151
+2,293
| +0.8% | +$85.5K |
|
|
SPTN
2060
DELISTED
SpartanNash
SPTN
| $9.15M | ﹤0.01% |
417,967
+13,846
| +3% | +$279K |
|
2061
Cooper-Standard Automotive
CPS
$484M
| $9.14M | ﹤0.01% |
417,376
-63,816
| -13% | -$1.53M |
|
2062
RadNet
RDNT
$6.08B
| $9.11M | ﹤0.01% |
310,898
+8,877
| +3% | +$285K |
|
|
SP
2063
DELISTED
SP Plus Corporation
SP
| $9.11M | ﹤0.01% |
296,957
-562
| -0.2% | -$17.4K |
|
2064
Manitowoc
MTW
$753M
| $9.07M | ﹤0.01% |
423,523
-3,202
| -0.8% | -$74.1K |
|
2065
GrowGeneration
GRWG
$108M
| $9.07M | ﹤0.01% |
367,525
+7,282
| +2% | +$257K |
|
2066
Rocket Pharmaceuticals
RCKT
$367M
| $9.07M | ﹤0.01% |
303,304
+6,289
| +2% | +$229K |
|
2067
Ethan Allen Interiors
ETD
$583M
| $9.03M | ﹤0.01% |
380,900
-680
| -0.2% | -$16.8K |
|
2068
Surgery Partners
SGRY
$1.99B
| $8.99M | ﹤0.01% |
212,274
-1,646
| -0.8% | -$84K |
|
|
BRMK
2069
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $8.96M | ﹤0.01% |
909,201
+39,216
| +5% | +$408K |
|
2070
Anavex Life Sciences
AVXL
$303M
| $8.96M | ﹤0.01% |
499,206
+340,353
| +214% | +$6.77M |
|
2071
Marqeta
MQ
$1.71B
| $8.95M | ﹤0.01% |
+101,165
| New | +$10.8M |
|
2072
Seer Inc
SEER
$116M
| $8.94M | ﹤0.01% |
258,834
+164,527
| +174% | +$5.66M |
|
|
AVID
2073
DELISTED
Avid Technology Inc
AVID
| $8.92M | ﹤0.01% |
308,429
-27,718
| -8% | -$856K |
|
2074
Innoviva
INVA
$1.5B
| $8.92M | ﹤0.01% |
533,564
-18,975
| -3% | -$284K |
|
2075
Agilysys
AGYS
$3.25B
| $8.91M | ﹤0.01% |
170,202
-3,041
| -2% | -$166K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.